Amphastar Pharmaceuticals
AMPH
AMPH
203 hedge funds and large institutions have $1.07B invested in Amphastar Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 69 increasing their positions, 61 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.01% more ownership
Funds ownership: 60.96% → 61.98% (+1%)
93% less call options, than puts
Call options by funds: $2.66M | Put options by funds: $37.6M
Holders
203
Holding in Top 10
3
Calls
$2.66M
Puts
$37.6M
Top Buyers
| 1 | +$9.04M | |
| 2 | +$8.41M | |
| 3 | +$6.42M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$6.28M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
+$5.54M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$17M | |
| 3 | -$6.1M | |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$4.57M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.21M |